Vaxart, Inc. (VXRT)
OTCMKTS · Delayed Price · Currency is USD
0.5900
+0.0330 (5.92%)
At close: Feb 20, 2026
Vaxart Market Cap
Vaxart has a market cap or net worth of $141.59 million as of February 20, 2026. Its market cap has decreased by -18.67% in one year.
Market Cap
141.59M
Enterprise Value
131.75M
Revenue
148.20M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.59
Market Cap Chart
Since February 14, 2018, Vaxart's market cap has increased from 60.35M to 141.59M, an increase of 134.61%. That is a compound annual growth rate of 11.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 141.59M | 70.32% |
| Dec 31, 2025 | 83.13M | -44.81% |
| Dec 31, 2024 | 150.61M | 72.95% |
| Dec 29, 2023 | 87.09M | -30.95% |
| Dec 30, 2022 | 126.12M | -83.97% |
| Dec 31, 2021 | 786.86M | 25.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Feb 14, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Northwest Biotherapeutics | 383.41M |
| CytoDyn | 330.55M |
| Silence Therapeutics | 236.17M |
| HST Global | 139.70M |
| BioStem Technologies | 101.71M |
| Nuo Therapeutics | 77.26M |
| Vicapsys Life Sciences | 48.56M |
| Arch Biopartners | 44.53M |